Cargando…
Hodgkin’s Lymphoma in Older Patients: an Orphan Disease?
Hodgkin Lymphoma HL can be cured in the large majority of younger patients, but prognosis for older patients, especially those with advanced-stage disease, has not improved substantially. The percentage of HL patients aged over 60 ranges between 15% and 35%. A minority of them is enrolled into clini...
Autores principales: | Thyss, Antoine, Saada, Esma, Gastaud, Lauris, Peyrade, Frédéric, Re, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103506/ https://www.ncbi.nlm.nih.gov/pubmed/25045458 http://dx.doi.org/10.4084/MJHID.2014.050 |
Ejemplares similares
-
Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma
por: Tardy, Magalie P., et al.
Publicado: (2015) -
Primary Multicentric Angiosarcoma of Bone: True Entity or Metastases from an Unknown Primary? Value of Comparative Genomic Hybridization on Paraffin Embedded Tissues
por: Thariat, Juliette, et al.
Publicado: (2013) -
Very Late Local Relapse of Ewing's Sarcoma of the Head and Neck treated with Aggressive Multimodal Therapy
por: Thariat, J., et al.
Publicado: (2008) -
Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib
por: Bailleux, Caroline, et al.
Publicado: (2014) -
Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
por: De Re, Valli, et al.
Publicado: (2019)